XML 64 R40.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Acquisitions - Additional Information (Details) $ in Thousands |  |  |  |  | 36 Months Ended
--- | --- | --- | --- | --- | ---
Sep. 09, 2020 USD ($) | Sep. 08, 2020 USD ($) | Apr. 01, 2020 USD ($) | Jul. 23, 2019 USD ($) | Dec. 31, 2021 Number
Business Acquisition [Line Items] |  |  |  |  |
Number of acquisitions | Number |  |  |  |  | 4
Number of businesses acquired | Number |  |  |  |  | 2
Taurus Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Percentage share of post clinical acquire product revenues | 25.00% |  |  |  |
Business combination consideration transferred | $ 5,200 |  |  |  |
Payments to acquire businesses gross | 4,600 |  |  |  |
Business combination consideration transferred liabilities incurred | 500 |  |  |  |
Business combination consideration transferred earnout rights | 4,500 |  |  |  |
Taurus Acquisition [Member] | Research and Development Expense [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business combination consideration transferred earnout rights | $ 25,000 |  |  |  |
xCella Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Percentage share of future milestone payments |  | 25.00% |  |  |
Business combination consideration transferred |  | $ 7,100 |  |  |
Business combination consideration transferred liabilities incurred |  | 500 |  |  |
Business combination consideration transferred earnout rights |  | 5,000 |  |  |
xCella Acquisition [Member] | Research and Development Expense [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business combination consideration transferred earnout rights |  | $ 25,750 |  |  |
Icagen Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life |  |  | 9 years 8 months 12 days |  |
Business combination consideration transferred |  |  | $ 19,900 |  |
Payments to acquire businesses gross |  |  | 15,100 |  |
Business combination contingent consideration revenue milestone payment |  |  | $ 4,800 |  |
Business combination cash flow discounted rate |  |  | 17.00% |  |
Ab Initio Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business combination consideration transferred |  |  |  | $ 12,000 |
Payments to acquire businesses gross |  |  |  | $ 11,900 |
Business combination cash flow discounted rate |  |  |  | 12.00% |
Business combination consideration transferred to holdback for potential indemnification claims |  |  |  | $ 150 |
Technology-Based Intangible Assets [Member] | Taurus Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life | 10 years |  |  |  |
Technology-Based Intangible Assets [Member] | xCella Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life |  | 15 years |  |  |
Technology-Based Intangible Assets [Member] | Icagen Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life |  |  | 10 years |  |
Finite lived intangible assets acquired |  |  | $ 1,700 |  |
Technology-Based Intangible Assets [Member] | Ab Initio Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life |  |  |  | 20 years |
Customer Relationships [Member] | Icagen Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Acquired finite lived intangible assets weighted average useful life |  |  | 9 years 7 months 6 days |  |
Finite lived intangible assets acquired |  |  | $ 11,100 |  |
Earnout Rights [Member] | Icagen Acquisition [Member] |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business combination contingent consideration arrangements range of outcomes value high |  |  | $ 25,000 |  |

X
- Definition Business combination cash flow discounted rate. + References No definition available. + Details
Name: | oabi_BusinessCombinationCashFlowDiscountedRate
Namespace Prefix: | oabi_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business combination, consideration transferred, earnout rights. + References No definition available. + Details
Name: | oabi_BusinessCombinationConsiderationTransferredEarnoutRights
Namespace Prefix: | oabi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business combination consideration transferred holdback for potential indemnification claims. + References No definition available. + Details
Name: | oabi_BusinessCombinationConsiderationTransferredHoldbackForPotentialIndemnificationClaims
Namespace Prefix: | oabi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business combination contingent consideration revenue milestone payment. + References No definition available. + Details
Name: | oabi_BusinessCombinationContingentConsiderationRevenueMilestonePayment
Namespace Prefix: | oabi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of acquisitions. + References No definition available. + Details
Name: | oabi_NumberOfAcquisitions
Namespace Prefix: | oabi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage share of future milestone payments. + References No definition available. + Details
Name: | oabi_PercentageShareOfFutureMilestonePayments
Namespace Prefix: | oabi_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage share of post clinical acquiree product revenues. + References No definition available. + Details
Name: | oabi_PercentageShareOfPostClinicalAcquireeProductRevenues
Namespace Prefix: | oabi_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(3) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of businesses acquired by the entity during the period. + References No definition available. + Details
Name: | us-gaap_NumberOfBusinessesAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=oabi_TaurusAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=oabi_XCellaAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=oabi_IcagenAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=oabi_AbInitioAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=oabi_EarnoutRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |